Literature DB >> 7620188

The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: identification of a new mutation on the alpha IIb gene.

N Schlegel1, O Gayet, M C Morel-Kopp, B Wyler, M F Hurtaud-Roux, C Kaplan, J Mc Gregor.   

Abstract

Glanzmann's thrombasthenia is a rare inherited bleeding disorder caused by a qualitative or quantitative defect of platelet alpha IIb beta 3. We describe here a new mutation that is the molecular genetic basis of Glanzmann's thrombasthenia in two gypsy families. Our investigation was focused on the alpha IIb gene as a result of biochemical and immunologic analysis of patients' platelets showing undetectable alpha IIb but residual beta 3 levels. The entire alpha IIb cDNA was polymerase chain reaction (PCR) amplified using patients platelet RNA. Sequence analysis showed an 8-bp deletion located at the 3' end of exon 15. This deletion causes a reading-frame shift leading to a premature stop codon and the synthesis of a severely truncated form of alpha IIb. Genomic DNA study showed a G-->A substitution, the Gypsy mutation, at the splice donor site of intron 15. This mutation results in an abnormal splicing occurring at an alternative donor site located 8 bp upstream from the mutation. Based on those results, an allele-specific PCR analysis was developed to allow a rapid identification of the mutation in patients and potential carriers of the gypsy community. This PCR analysis can also be used for genetic counseling and antenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620188

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.

Authors:  Dana Gabrikova; Martin Mistrik; Jarmila Bernasovska; Alexandra Bozikova; Regina Behulova; Iveta Tothova; Sona Macekova
Journal:  J Appl Genet       Date:  2013-08-31       Impact factor: 3.240

2.  Sequential regulation of the small GTPase Rap1 in human platelets.

Authors:  B Franke; M van Triest; K M de Bruijn; G van Willigen; H K Nieuwenhuis; C Negrier; J W Akkerman; J L Bos
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families.

Authors:  Mathieu Fiore; Xavier Pillois; Paquita Nurden; Alan T Nurden; Frédéric Austerlitz
Journal:  Eur J Hum Genet       Date:  2011-04-13       Impact factor: 4.246

4.  Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

Authors:  Y Jin; H C Dietz; R A Montgomery; W R Bell; I McIntosh; B Coller; P F Bray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 5.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

6.  A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.

Authors:  N Rosenberg; H Hauschner; H Peretz; R Mor-Cohen; M Landau; B Shenkman; G Kenet; B S Coller; A A Awidi; U Seligsohn
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

7.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

Review 8.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

Review 9.  Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

Authors:  Natalie Mathews; Georges-Etienne Rivard; Arnaud Bonnefoy
Journal:  J Blood Med       Date:  2021-06-11

Review 10.  Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Authors:  Alan Nurden
Journal:  J Blood Med       Date:  2021-07-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.